Tru-D emits UV light that modifies the genetic structure of an infectious cell to effectively kill germs and bacteria. The device calculates the amount of UV energy required to disinfect a room, accounting for variables like size, geometry and equipment layout. Tru-D is used after a staff member disinfects the room via traditional methods.
“The acquisition of this technology is simply another way that we’re working to safeguard the well-being of every single patient who walks through our doors and protect the integrity of our healthcare environment,” said Gar Atchison, CEO of Frye Regional Medical Center.
More articles on infection control and clinical quality:
Glendale Adventist Medical Center’s ban on vaginal-breech deliveries sparks activist protests
Pennsylvania reports its 1st sexually transmitted Zika case
NIH, HHS offer up to $20M in prizes for antibiotic resistance-combating solutions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
